Meyer, Larissa A <br/><br/>
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  May 2014 
 - 713-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1097/IGC.0000000000000118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Endometrial Neoplasms--drug therapy<br/>Everolimus<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Immunosuppressive Agents--therapeutic use<br/>Mutation--genetics<br/>Neoplasm Grading<br/>PTEN Phosphohydrolase--metabolism<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>ras Proteins--genetics